79 related articles for article (PubMed ID: 21907639)
21. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
Panagea S; Winstanley C; Walshaw MJ; Ledson MJ; Hart CA
J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443
[TBL] [Abstract][Full Text] [Related]
22. Secretome of transmissible Pseudomonas aeruginosa AES-1R grown in a cystic fibrosis lung-like environment.
Scott NE; Hare NJ; White MY; Manos J; Cordwell SJ
J Proteome Res; 2013 Dec; 12(12):5357-69. PubMed ID: 23991618
[TBL] [Abstract][Full Text] [Related]
23. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
[TBL] [Abstract][Full Text] [Related]
24. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
25. A diagnostic PCR assay for the detection of an Australian epidemic strain of Pseudomonas aeruginosa.
Williams HL; Turnbull L; Thomas SJ; Murphy A; Stinear T; Armstrong DS; Whitchurch CB
Ann Clin Microbiol Antimicrob; 2010 Jul; 9():18. PubMed ID: 20637114
[TBL] [Abstract][Full Text] [Related]
26. Cross-infections with Pseudomonas aeruginosa in patients with cystic fibrosis attending the Warsaw Centre.
Milczewska J; Wołkowicz T; Zacharczuk K; Kwiatkowska M
Dev Period Med; 2015; 19(1):60-5. PubMed ID: 26003071
[TBL] [Abstract][Full Text] [Related]
27. Pseudomonas aeruginosa diversity in distinct paediatric patient groups.
Tramper-Stranders GA; van der Ent CK; Wolfs TF; Kimpen JL; Fleer A; Johansen U; Johansen HK; Høiby N
Clin Microbiol Infect; 2008 Oct; 14(10):935-41. PubMed ID: 18752596
[TBL] [Abstract][Full Text] [Related]
28. Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres.
Doe SJ; McSorley A; Isalska B; Kearns AM; Bright-Thomas R; Brennan AL; Webb AK; Jones AM
J Cyst Fibros; 2010 Mar; 9(2):104-9. PubMed ID: 20051329
[TBL] [Abstract][Full Text] [Related]
29. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units.
O'Carroll MR; Syrmis MW; Wainwright CE; Greer RM; Mitchell P; Coulter C; Sloots TP; Nissen MD; Bell SC
Eur Respir J; 2004 Jul; 24(1):101-6. PubMed ID: 15293611
[TBL] [Abstract][Full Text] [Related]
30. Different opinions of physicians on the importance of measures to prevent acquisition of Pseudomonas aeruginosa from the environment.
Steinkamp G; Ullrich G
J Cyst Fibros; 2003 Dec; 2(4):199-205. PubMed ID: 15463874
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods.
Pressler T; Karpati F; Granström M; Knudsen PK; Lindblad A; Hjelte L; Olesen HV; Meyer P; Høiby N;
J Cyst Fibros; 2009 Jan; 8(1):37-42. PubMed ID: 18835753
[TBL] [Abstract][Full Text] [Related]
32. Lack of evidence of transmission of Pseudomonas aeruginosa among cystic fibrosis patients attending health camps at the Dead Sea, Israel.
Greenberg D; Yagupsky P; Peled N; Goldbart A; Porat N; Tal A
Isr Med Assoc J; 2004 Sep; 6(9):531-4. PubMed ID: 15373310
[TBL] [Abstract][Full Text] [Related]
33. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
Emerson J; Rosenfeld M; McNamara S; Ramsey B; Gibson RL
Pediatr Pulmonol; 2002 Aug; 34(2):91-100. PubMed ID: 12112774
[TBL] [Abstract][Full Text] [Related]
34. Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis.
Lebecque P; Leal T; Zylberberg K; Reychler G; Bossuyt X; Godding V
J Cyst Fibros; 2006 Dec; 5(4):237-44. PubMed ID: 16790367
[TBL] [Abstract][Full Text] [Related]
35. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.
Ojeniyi B
APMIS Suppl; 1994; 46():1-44. PubMed ID: 7811529
[TBL] [Abstract][Full Text] [Related]
36. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer J; Rosenfeld M
Clin Microbiol Infect; 2013 Nov; 19(11):E483-9. PubMed ID: 23795938
[TBL] [Abstract][Full Text] [Related]
37. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Ojeniyi B; Petersen US; Høiby N
APMIS; 1993 Feb; 101(2):168-75. PubMed ID: 8098219
[TBL] [Abstract][Full Text] [Related]
38. Homogentisate 1-2-Dioxygenase Downregulation in the Chronic Persistence of Pseudomonas aeruginosa Australian Epidemic Strain-1 in the CF Lung.
Harmer CJ; Wynn M; Pinto R; Cordwell S; Rose BR; Harbour C; Triccas JA; Manos J
PLoS One; 2015; 10(8):e0134229. PubMed ID: 26252386
[TBL] [Abstract][Full Text] [Related]
39. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
[TBL] [Abstract][Full Text] [Related]
40. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
Hansen CR; Pressler T; Koch C; Høiby N
J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
